A new trading day began on Monday, with Macrogenics Inc (NASDAQ: MGNX) stock price down -5.00% from the previous day of trading, before settling in for the closing price of $3.00. MGNX’s price has ranged from $2.91 to $21.88 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 18.02% over the past five years. Meanwhile, its annual earnings per share averaged -697.81%. With a float of $57.88 million, this company’s outstanding shares have now reached $62.76 million.
Let’s look at the performance matrix of the company that is accounted for 339 employees. In terms of profitability, gross margin is 91.14%, operating margin of -75.78%, and the pretax margin is -69.07%.
Macrogenics Inc (MGNX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Macrogenics Inc is 7.78%, while institutional ownership is 84.46%. The most recent insider transaction that took place on Apr 04 ’24, was worth 799,148. In this transaction Senior VP and General Counsel of this company sold 51,395 shares at a rate of $15.55, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 06 ’24, when Company’s Senior VP and General Counsel sold 19,625 for $21.50, making the entire transaction worth $421,938. This insider now owns 8,895 shares in total.
Macrogenics Inc (MGNX) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -697.81% per share during the next fiscal year.
Macrogenics Inc (NASDAQ: MGNX) Trading Performance Indicators
Here are Macrogenics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.57, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -2.20 in one year’s time.
Technical Analysis of Macrogenics Inc (MGNX)
Macrogenics Inc (NASDAQ: MGNX) saw its 5-day average volume 0.83 million, a positive change from its year-to-date volume of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 14.55%. Additionally, its Average True Range was 0.19.
During the past 100 days, Macrogenics Inc’s (MGNX) raw stochastic average was set at 0.44%, which indicates a significant decrease from 1.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.60% in the past 14 days, which was lower than the 60.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.27, while its 200-day Moving Average is $4.79. Nevertheless, the first resistance level for the watch stands at $2.94 in the near term. At $3.03, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.08. If the price goes on to break the first support level at $2.80, it is likely to go to the next support level at $2.75. The third support level lies at $2.66 if the price breaches the second support level.
Macrogenics Inc (NASDAQ: MGNX) Key Stats
With a market capitalization of 178.88 million, the company has a total of 62,763K Shares Outstanding. Currently, annual sales are 58,750 K while annual income is -9,060 K. The company’s previous quarter sales were 110,710 K while its latest quarter income was 56,310 K.
